Horizon Pharma (HZNP) Tops Q4 EPS by 13c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Intel shares fall as competitor reports record results
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Horizon Pharma plc Announces Fourth-Quarter and Full-Year 2016 Financial Results and Provides Full-Year 2017 Net Sales and Adjusted EBITDA Guidance
February 27, 2017 7:01 AM EST-- Fourth-Quarter 2016 Net Sales of $310.3 Million; Up 27 Percent ---- Fourth-Quarter 2016 Net Loss of $130.5 Million(1); Adjusted EBITDA of $136.4 Million --
-- Fourth-Quarter 2016 Operating Cash Flow of $139.2 Million;Fourth-Quarter 2016 Non-GAAP Operating Cash Flow of $193.1 Million --
-- Full-Year 2016 Net Sales of $981.1 Million(2);Full-Year 2016 Non-GAAP Adjusted Net Sales of $1,046.1 Million(2) --
-- Full-Year 2016 Net Loss of $166.8 Million(1); Adjusted EBITDA of $470.7 Million
-- Full-Year 2016 Operating Cash Flow of $369.5 Million;Full-Year 2016 Non-GAAP Operating Cash Flow of $452.9 Million;Year-End 2016 Cash Balance of $509.1 Million --
--... More



